May 27, 2010 - Researchers found radiologists have shown improvement in their ability to discriminate between cancerous and non-cancerous lesions over a nine-year period. Results of the study are published in the online edition of the journal Radiology.

“To our knowledge, this is the first study of time trends for performance measures in a large representative sample of women undergoing screening mammography in the United States,” said lead author Laura E. Ichikawa, M.S., biostatistician at the Group Health Research Institute in Seattle, Wash.

The research team examined data from six mammography registries in the Breast Cancer Surveillance Consortium. The data included 2,542,049 screening mammograms of 971,364 women (age 40 to 79) performed at healthcare facilities throughout the country between 1996 and 2004.

Each of the women included in the study had at least one prior mammogram and at least nine months in between mammography exams. Cancer registries and pathology databases were used to identify breast cancers that occurred within one year of any mammogram included in the study.

“We found universal trends that breast imagers are increasing their ability to detect and intercept breast cancer before a lump is felt by a woman,” said study co-author R. James Brenner, M.D., professor of clinical radiology at the University of California, San Francisco.

Analysis of the radiologists’ performance in interpreting the mammograms over the nine-year time period revealed an increase in the recall rate, or mammograms resulting in patients being called back for further evaluation, from 6.7 percent (10,779 of 160,329 mammograms) in 1996 to 8.6 percent (24,630 of 285,286) in 2004.

The sensitivity rate, or the ability of radiologists to identify cancer when present, increased from 71.4 percent in 1996 to 83.8 percent in 2004. The specificity rate, or the degree to which radiologists correctly identified non-cancerous lesions, decreased from 93.6 percent in 1996 to 91.7 percent in 2004.

According to Ichikawa, the increase in the cancer detection rate outweighed the increase in false-positive test results over the nine-year time period, for a positive net effect.

“This is good news for women and for radiology that we have seen a net improvement in how radiologists interpret mammograms,” she said. “Radiologists are doing a better job of discriminating cancer from non-cancer.”

A total of 12,498 invasive cancers and non-invasive cancers were diagnosed. An invasive cancer is a cancer that has spread beyond the layer of tissue where it developed and is growing into surrounding, healthy tissues. Overall, 78.7 percent of cancers included in the study were invasive.

The majority of mammograms included in the study were film studies. Ichikawa said future studies could focus on time trends of radiologists’ interpretive performance when reading digital mammograms. Digital mammography, which was just beginning to be adopted in healthcare institutions towards the end of this study, is now available in approximately half of all mammography facilities in the country.

Reference: “Time Trends in Radiologists’ Interpretive Performance at Screening Mammography from the Community-based Breast Cancer Surveillance Consortium, 1996-2004.” Collaborating with Ichikawa and Dr. Brenner were William E. Barlow, Ph.D., Melissa L. Anderson, M.S., Stephen Taplin, M.D., M.P.H., and Berta M. Geller, Ed.D.

For more information: www.rsna.org


Related Content

News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 05, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
Subscribe Now